Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases

Details for Australian Patent Application No. 2010325900 (hide)

Owner Synergy Pharmaceuticals, Inc.

Inventors Shailubhai, Kunwar

Agent Cullens

Pub. Number AU-A-2010325900

PCT Pub. Number WO2011/069038

Priority 12/630,654 03.12.09 US

Filing date 3 December 2010

Wipo publication date 9 June 2011

International Classifications

A61K 38/10 Medicinal preparations containing peptides - Peptides having 12 to 20 amino acids

A61P 1/00 Drugs for disorders of the alimentary tract or the digestive system

A61P 5/00 Drugs for disorders of the endocrine system

A61P 9/00 Drugs for disorders of the cardiovascular system

Event Publications

21 June 2012 PCT application entered the National Phase

  PCT publication WO2011/069038 Priority application(s): WO2011/069038

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010325908-Composition and methods for the prevention and treatment of macular degeneration, diabetic retinopathy, and diabetic macular edema

2010325897-Multifunction multimedia device